Frontiers in Microbiology (Jan 2024)

Anticancer activities of natural antimicrobial peptides from animals

  • Baozhen Qu,
  • Jiangshui Yuan,
  • Xueli Liu,
  • Xueli Liu,
  • Shicui Zhang,
  • Shicui Zhang,
  • Xuezhen Ma,
  • Linlin Lu

DOI
https://doi.org/10.3389/fmicb.2023.1321386
Journal volume & issue
Vol. 14

Abstract

Read online

Cancer is the most common cause of human death worldwide, posing a serious threat to human health and having a negative impact on the economy. In the past few decades, significant progress has been made in anticancer therapies, but traditional anticancer therapies, including radiation therapy, surgery, chemotherapy, molecular targeted therapy, immunotherapy and antibody-drug conjugates (ADCs), have serious side effects, low specificity, and the emergence of drug resistance. Therefore, there is an urgent need to develop new treatment methods to improve efficacy and reduce side effects. Antimicrobial peptides (AMPs) exist in the innate immune system of various organisms. As the most promising alternatives to traditional drugs for treating cancers, some AMPs also have been proven to possess anticancer activities, which are defined as anticancer peptides (ACPs). These peptides have the advantages of being able to specifically target cancer cells and have less toxicity to normal tissues. More and more studies have found that marine and terrestrial animals contain a large amount of ACPs. In this article, we introduced the animal derived AMPs with anti-cancer activity, and summarized the types of tumor cells inhibited by ACPs, the mechanisms by which they exert anti-tumor effects and clinical applications of ACPs.

Keywords